v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 368,796 $ 228,713
Marketable securities, at fair value 202,950 67,546
Accounts receivable, net 106,284 106,843
Inventories 21,384 29,526
Prepaid assets 13,959 11,547
Other current assets 8,422 4,555
Total current assets 721,795 448,730
Property and equipment (net of accumulated depreciation of $105,194 and $92,895, respectively) 112,208 85,873
Operating lease right-of-use assets 54,558 45,786
Intangible assets, net 471,038 120,653
Goodwill 499,977 211,083
Restricted cash 4,103 21,919
Investment in non-consolidated affiliate 0 29,555
Prepaid lease asset 24,958 20,229
Other assets 7,674 4,503
Total non-current assets 1,174,516 539,601
Total assets 1,896,311 988,331
Current liabilities    
Accounts payable 23,056 24,965
Accrued compensation 38,719 24,727
Accrued expenses and other liabilities 25,304 11,654
Current portion of equipment financing obligations 1,913 2,841
Current portion of operating lease liabilities 5,642 4,967
Pharma contract liabilities 4,497 4,029
Total current liabilities 99,131 73,183
Long-term liabilities    
Convertible senior notes, net 531,077 168,120
Long-term debt, net 448 967
Operating lease liabilities 49,624 42,296
Deferred income tax liabilities, net 63,877 5,415
Other long-term liabilities 3,796 4,056
Total long-term liabilities 648,822 220,854
Total liabilities 747,953 294,037
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 122,711,352 and 112,075,474 shares issued and outstanding, respectively) 123 112
Additional paid-in capital 1,101,298 701,357
Accumulated other comprehensive (loss) income (333) 10
Retained earnings (accumulated deficit) 47,270 (7,185)
Total stockholders’ equity 1,148,358 694,294
Total liabilities and stockholders’ equity $ 1,896,311 $ 988,331

Source